Joana A.D. Sequeira

725 total citations
10 papers, 505 citations indexed

About

Joana A.D. Sequeira is a scholar working on Molecular Biology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joana A.D. Sequeira has authored 10 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joana A.D. Sequeira's work include Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Joana A.D. Sequeira is often cited by papers focused on Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Joana A.D. Sequeira collaborates with scholars based in Portugal, United States and United Kingdom. Joana A.D. Sequeira's co-authors include Francisco Veiga, Ana Cláudia Paiva‐Santos, António J. Ribeiro, Raquel Seiça, João P. Serra, Irina Pereira, Margarida Viola, Ana Simões, Miguel Pereira‐Silva and Diana Peixoto and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and The Analyst.

In The Last Decade

Joana A.D. Sequeira

9 papers receiving 480 citations

Peers

Joana A.D. Sequeira
Joana A.D. Sequeira
Citations per year, relative to Joana A.D. Sequeira Joana A.D. Sequeira (= 1×) peers Yingying Li

Countries citing papers authored by Joana A.D. Sequeira

Since Specialization
Citations

This map shows the geographic impact of Joana A.D. Sequeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joana A.D. Sequeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joana A.D. Sequeira more than expected).

Fields of papers citing papers by Joana A.D. Sequeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joana A.D. Sequeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joana A.D. Sequeira. The network helps show where Joana A.D. Sequeira may publish in the future.

Co-authorship network of co-authors of Joana A.D. Sequeira

This figure shows the co-authorship network connecting the top 25 collaborators of Joana A.D. Sequeira. A scholar is included among the top collaborators of Joana A.D. Sequeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joana A.D. Sequeira. Joana A.D. Sequeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Brito, Dulce, Cândida Fonseca, Fátima Franco, et al.. (2024). Beyond clinical trials – The cost saving associated with dapagliflozin use in Portugal hospital clinical practice. Revista Portuguesa de Cardiologia. 43(12). 685–694.
2.
Collado-González, Mar, Ana Cláudia Paiva‐Santos, Nuno R. Ferreira, et al.. (2020). Complex Polysaccharide-Based Nanocomposites for Oral Insulin Delivery. Marine Drugs. 18(1). 55–55. 20 indexed citations
3.
Paiva‐Santos, Ana Cláudia, Joana A.D. Sequeira, Irina Pereira, et al.. (2019). Sonication-assisted Layer-by-Layer self-assembly nanoparticles for resveratrol delivery. Materials Science and Engineering C. 105. 110022–110022. 11 indexed citations
4.
Paiva‐Santos, Ana Cláudia, Francisco Veiga, Joana A.D. Sequeira, et al.. (2019). First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats – a pharmacokinetics study. The Analyst. 144(6). 2062–2079. 31 indexed citations
5.
Paiva‐Santos, Ana Cláudia, Joana A.D. Sequeira, Irina Pereira, et al.. (2019). Nanotechnological breakthroughs in the development of topical phytocompounds-based formulations. International Journal of Pharmaceutics. 572. 118787–118787. 65 indexed citations
6.
Paiva‐Santos, Ana Cláudia, Ana Simões, Irina Pereira, et al.. (2019). Nanotechnology for the development of new cosmetic formulations. Expert Opinion on Drug Delivery. 16(4). 313–330. 127 indexed citations
7.
Sequeira, Joana A.D., Ana Cláudia Paiva‐Santos, João P. Serra, et al.. (2019). Subcutaneous delivery of biotherapeutics: challenges at the injection site. Expert Opinion on Drug Delivery. 16(2). 143–151. 42 indexed citations
8.
Viola, Margarida, Joana A.D. Sequeira, Raquel Seiça, et al.. (2018). Subcutaneous delivery of monoclonal antibodies: How do we get there?. Journal of Controlled Release. 286. 301–314. 164 indexed citations
9.
Sequeira, Joana A.D., et al.. (2016). Pruritic hyperpigmented patch on back.. PubMed. 65(8). 559–61. 1 indexed citations
10.
Ribeiro, António J., Marlene Lopes, Bárbara Abrahim-Vieira, et al.. (2015). Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. International Journal of Nanomedicine. 10. 5865–5865. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026